Drug drug strategy block a major driver of the cancer

Using a new strategy, researchers from the University of California at San (UCSF Helen Diller Family Comprehensive Cancer Center home ） to target the mutant RAS protein, small molecules have been successful without bind irreversibly normal form. Differentiate this function in cancer, targeted drug therapy every other molecular scientists. People grow up in the culture when you test your lung cancer cells molecule killed RAS driven cancer cells effectively.

View the original article here